Aug 11 (Reuters) - Surface Oncology Inc SURF.O :
* SURFACE ONCOLOGY REPORTS FINANCIAL RESULTS AND CORPORATE
HIGHLIGHTS FOR SECOND QUARTER 2020
* Q2 LOSS PER SHARE $0.44
* Q2 EARNINGS PER SHARE ESTIMATE $-0.48 -- REFINITIV IBES
DATA
* SURFACE ONCOLOGY - AS OF JUNE 30, CASH, CASH EQUIVALENTS
AND
MARKETABLE SECURITIES WERE $112.5 MILLION, COMPARED TO $105.2
MILLION ON DECEMBER 31, 2019
* SURFACE ONCOLOGY - CONTINUES TO PROJECT THAT CURRENT CASH
AND
CASH EQUIVALENTS ARE SUFFICIENT TO FUND CO INTO 2022
Source text for Eikon: ID:nGNX6qkly7
Further company coverage: SURF.O
((Reuters.Briefs@thomsonreuters.com;))